Please provide your email address to receive an email when new articles are posted on . Flushing and erythema were reduced in patients using erenumab, a CGRP receptor antagonist. Adverse events were ...

Please provide your email address to receive an email when new articles are posted on . DENVER — A cream with heparin sulfate analog successfully reduced erythema in patients with rosacea, according ...

The US Food and Drug Administration (FDA) has approved oxymetazoline hydrochloride 1% cream (Rhofade, Allergan) for the topical treatment of persistent facial erythema associated with rosacea in ...

SCOTTSDALE, Ariz., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses ...

The US Food and Drug Administration (FDA) has approved brimonidine topical gel 0.33% (Mirvaso, Galderma Laboratories) for facial redness resulting from rosacea in adults aged 18 years or older, the ...

Rhofade ® (oxymetazoline 1% hydrochloride) cream is one of only two topical treatments approved by the FDA to treat this aspect of the disease 1 CHARLESTON, SC / ACCESSWIRE / September 2, 2021 / EPI ...

Even though rosacea is one of the most prevalent inflammatory skin diseases for which patients seek care in dermatology clinics, treatment options for the erythema and flushing associated with rosacea ...

Many patients with rosacea experience irritation or limited efficacy with existing therapies. Transcutaneous auricular vagus nerve stimulation reduced facial flushing and erythema in patients with ...

In 2 short‑term randomised controlled trials (RCTs: n=553) brimonidine tartrate gel was statistically significantly more effective than vehicle gel in reducing erythema in people with a clinical ...

MIRVASO (brimonidine) 0.33% Topical Gel The FDA has approved Galderma's Mirvaso (brimonidine) topical gel for the topical treatment of the facial erythema associated with rosacea in adults 18 years or ...

In 2 short‑term randomised controlled trials (RCTs: n=553) brimonidine tartrate gel was statistically significantly more effective than vehicle gel in reducing erythema in people with a clinical ...